Cresco Labs Inc (CL)

According to statistics from Viridian Capital Advisors, a data analytics and investment banking firm based in New York, there was a 33% drop in the value of mergers and acquisitions (M&A) from the $1.74bn in 2023 to the $1.16bn registered last year. Frank Colombo, the MD of Viridian discussed a number of factors that could explain this trend.

According to statistics from Viridian Capital Advisors, a data analytics and investment banking firm based in New York, there was a 33% drop in the value of mergers and acquisitions (M&A) from the $1.74bn in 2023 to the $1.16bn registered last year. Frank Colombo, the MD of Viridian discussed a number of factors that could explain this trend.

A contentious bipartisan measure aimed at addressing the high potency of cannabis in Colorado was withdrawn by its sponsors during a committee hearing. The measure faced immediate backlash, particularly over proposed regulations on specific edibles and age restrictions.

A contentious bipartisan measure aimed at addressing the high potency of cannabis in Colorado was withdrawn by its sponsors during a committee hearing. The measure faced immediate backlash, particularly over proposed regulations on specific edibles and age restrictions.

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter and year ended December 31, 2024. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, here.

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced its management services agreement with a Tier 3 Cultivation License in Kentucky (the “Cultivation License”). The agreement entitles Cresco Labs to manage and operate a cultivation facility with up to 25,000 square feet of canopy, marking a significant milestone for the Company and establishing Cresco Labs as one of only two operators of Kentucky’s coveted Tier 3 cultivation licenses.

Senate Republicans in Ohio claim that voters weren’t properly informed of what they were voting for when they approved the state’s recreational cannabis legalization ballot measure in 2023 and have passed a bill to restrict the measure. According to the Ohio GOP, voters across the state weren’t aware of what they were approving when they voted to legalize cannabis.

Senate Republicans in Ohio claim that voters weren’t properly informed of what they were voting for when they approved the state’s recreational cannabis legalization ballot measure in 2023 and have passed a bill to restrict the measure. According to the Ohio GOP, voters across the state weren’t aware of what they were approving when they voted to legalize cannabis.

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the fourth quarter and year ended December 31st, 2024 on Wednesday, March 12, 2025 before the market opens.

The Department of Treasury in Michigan announced on Friday that it will be distributing approximately $100m in cannabis tax revenue to 302 local communities and tribes. Detroit stands out as it will receive over $3m, the largest amount that any community in the state will receive.

The Department of Treasury in Michigan announced on Friday that it will be distributing approximately $100m in cannabis tax revenue to 302 local communities and tribes. Detroit stands out as it will receive over $3m, the largest amount that any community in the state will receive.

Two U.S. Senators have teamed up with prohibitionists to work on legislation that would block marijuana firms from receiving potential tax relief under Schedule III of the Controlled Substances Act. Senators Pete Ricketts and James Lankford are working with Smart Approaches to Marijuana to block 280E relief for state-sanctioned cannabis companies in the U.S.

Missouri courts are close to completing their review of cannabis expungements after expunging hundreds of thousands of cannabis cases. The review began after Missouri voters approved a constitutional amendment to legalize adult use marijuana in 2022 and has seen state courts expunge over 300,000 cases.

A ransomware attack in California has compromised the data of hundreds of thousands of cannabis customers across the state. Stiiizy, a marijuana brand based in California, recently notified 380,000 customers that their data had been compromised in a phishing attack against one of its vendors. The cannabis brand confirmed the alert via a data breach notification to the Maine Attorney General’s Office stating that on November 20, 2024, one of its point-of-sale processing services vendors notified it of a massive data breach at several retail locations.

Voters in Arkansas approved a measure to legalize medical marijuana in 2016 and the state finally began sales in mid-2019 with about 11,000 registered medical marijuana patients. Arkansas’s medical cannabis program has expanded significantly in the years since as more patients registered, reaching 101,006 active MMJ cards in June 2024 and 108,957 by the end of the year.

New laws in the United States are making it possible to include THC in beverages, offering what some see as a potential alcohol alternative. While this development is being met with optimism by some, others believe its benefits may vary.

A top medical marijuana opponent in Nebraska has initiated a new legal challenge aiming to nullify two recent ballot initiatives to legalize and regulate marijuana in the state.

A recent study examining the use of prescribed opioids in Utah after medical cannabis legalization in the state highlights a significant reduction in opioid consumption among patients managing chronic pain. The findings also show a substantial decline in opioid prescription-related deaths since Utah authorized medical marijuana in 2018.

The journey toward cannabis legalization in the United States has been significant, with nearly half of the states now allowing its recreational use. However, the topic remains contentious and divisive, frequently leveraged by politicians. Some invoke fears about potential harm to oppose legalization, while others emphasize benefits such as increased revenue and reduced violent crime to advocate for it.

With recent shifts in political power, many are questioning if a Republican-led government might better support cannabis reform than one led by Democrats. As former President Donald Trump returns to the White House and Republicans take control of the Senate, the $32 billion U.S. cannabis industry stands at a crucial point, uncertain about the future of legalization.

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the third quarter ended September 30, 2024. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, here.

Kentucky is making significant progress toward introducing medical cannabis as an option for healthcare in the state. Recently, 26 businesses were chosen to cultivate and process medical cannabis, which will soon be available for sale across Kentucky. The businesses earned their licenses through a random lottery held at the Kentucky Lottery office in Louisville.

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the third quarter ended September 30th, 2024 on Friday, November 8th, 2024 before the market opens.

Nebraska’s top election official and the state’s chief prosecutor are raising concerns about the validity of most signatures gathered for two medical marijuana petitions set to appear on the ballot this November. Mike Hilgers, Nebraska’s attorney general, who filed a legal motion on behalf of Bob Evnen, secretary of state, stated that inquiries are still being conducted to determine whether the 49,000-plus confirmed signatures on these petitions are authentic.

Amid a shaky economy, the marijuana industry seems to be thriving, with many premium brands raking in huge profits. Brand Marketing VP at Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) , Dana Mason, argues that consumers want the best and individuals who appreciate premium products are willing to pay more.